 | WSJ: Pfizer to reverse course, raise prices on 41 drugs
seekingalpha.com - November 16 at 3:40 PM |
 | Pfizer plans to increase U.S. drug prices in January
finance.yahoo.com - November 16 at 3:40 PM |
| [$$] Pfizer to Raise Prices on 41 Drugs
finance.yahoo.com - November 16 at 3:40 PM |
| Final Trades: Virtu, JPMorgan & Pfizer
finance.yahoo.com - November 16 at 3:40 PM |
| Pfizer to raise prices on 41 prescription drugs next year despite pressure from Trump
finance.yahoo.com - November 16 at 3:40 PM |
 | Top Research Reports for Pfizer, Cisco & Southern Company
www.zacks.com - November 16 at 10:06 AM |
| AstraZeneca Shows It Can Still Take Some Knocks
finance.yahoo.com - November 16 at 10:06 AM |
 | Global Hyperlipidemia Drugs Market Analysis (2016-2022): AstraZeneca, Merck, Pfizer, Daiichi Sankyo, Amgen and Sanofi are Profiled
www.prnewswire.com - November 15 at 7:31 PM |
| Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes
finance.yahoo.com - November 15 at 3:37 PM |
 | Why Pfizer Is Up 19% in 2018 So Far
www.fool.com - November 15 at 8:54 AM |
 | Pfizer (PFE) Earns Daily Media Impact Rating of 0.83
www.americanbankingnews.com - November 14 at 8:58 PM |
 | IVE, WMT, PFE, MRK: Large Inflows Detected at ETF
www.nasdaq.com - November 14 at 3:38 PM |
| Pfizer loses drug patent fight in UK top court, may face claims
finance.yahoo.com - November 14 at 3:38 PM |
| Pfizer loses Lyrica patent fight
seekingalpha.com - November 14 at 10:01 AM |
 | Pfizer loses its Lyrica drug patent fight in UK Supreme Court
www.cnbc.com - November 14 at 7:24 AM |
| Pfizer (PFE) Stock Moves -0.38%: What You Should Know
www.zacks.com - November 13 at 10:00 AM |
| Pfizer Inc. (PFE) Short Interest Down 7.5% in October
www.americanbankingnews.com - November 13 at 2:40 AM |
| Positive Media Coverage Unlikely to Impact Pfizer (PFE) Stock Price
www.americanbankingnews.com - November 10 at 7:20 PM |
 | This Health Care Stock Could Pay Off Big
investorplace.com - November 9 at 9:51 AM |
| Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up
finance.yahoo.com - November 8 at 3:43 PM |
| Pfizer (PFE) Given a $53.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - November 8 at 12:16 PM |
| Why Pfizer’s Rare Disease Portfolio Offers a Unique Opportunity
finance.yahoo.com - November 7 at 10:50 AM |
| Eli Lilly's Conservative Pricing Offers Protection From Political Pressure
finance.yahoo.com - November 6 at 3:39 PM |
| Pfizer (PFE) PT Raised to $37.00
www.americanbankingnews.com - November 6 at 10:52 AM |
 | Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and ...
www.streetinsider.com - November 6 at 10:42 AM |
| Xeljanz: PFE’s Immunology and Inflammation Growth Driver
finance.yahoo.com - November 6 at 10:42 AM |
| Vaccines Are an Important Growth Driver for Pfizer
finance.yahoo.com - November 6 at 10:42 AM |
| Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Pfizer (PFE) Share Price
www.americanbankingnews.com - November 6 at 8:25 AM |
| Pfizer Inc. (PFE) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 3:20 AM |
| Analyzing Gilead Sciences’ HIV Portfolio
finance.yahoo.com - November 5 at 8:31 AM |
| Analyzing Pfizer’s Expense Projections for 2018
finance.yahoo.com - November 5 at 8:31 AM |
| Zacks: Brokerages Anticipate Pfizer Inc. (PFE) Will Post Quarterly Sales of $13.91 Billion
www.americanbankingnews.com - November 4 at 3:26 AM |
| Pfizer mulling sale of women's health products - Bloomberg
seekingalpha.com - November 3 at 3:31 PM |
| FDA OKs Pfizer's lorlatinib for lung cancer
seekingalpha.com - November 3 at 10:43 AM |
| Brokerages Anticipate Pfizer Inc. (PFE) Will Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - November 2 at 5:03 PM |
 | Ibrance, Eliquis, And Biosimilars Remain The Key Driver For Pfizer's Future Earnings Growth
www.forbes.com - November 2 at 3:32 PM |
| Pfizer’s Earnings Projections for 2018
finance.yahoo.com - November 2 at 3:32 PM |
| PFE vs. NVO: Which Stock Is the Better Value Option?
www.zacks.com - November 2 at 11:15 AM |
 | BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'
www.benzinga.com - November 2 at 11:15 AM |
| Evaluating Pfizer's Growth Plans And Valuation
seekingalpha.com - November 2 at 11:15 AM |
| Here’s How Pfizer Stock Moved in October
finance.yahoo.com - November 2 at 11:15 AM |
 | Drug giant Pfizer says it will return to 'business as normal,' which means price hikes
www.latimes.com - November 2 at 8:58 AM |
| Pfizer (PFE) said to Weigh Sale of $2B Women's Health Portfolio - Bloomberg
www.streetinsider.com - November 1 at 3:37 PM |
| PFE vs. NVO: Which Stock Should Value Investors Buy Now?
www.zacks.com - November 1 at 3:37 PM |
| Pfizer cut to market perform at BMO
finance.yahoo.com - November 1 at 3:37 PM |
| Pfizer (PFE) Downgraded by BMO Capital Markets
www.americanbankingnews.com - November 1 at 2:15 PM |
| Pfizer (PFE) Given a $43.00 Price Target by Societe Generale Analysts
www.americanbankingnews.com - November 1 at 12:47 PM |
| Pfizer downgraded by BMO: 'Significant headwinds' will cap the drugmaker's stock run
finance.yahoo.com - November 1 at 10:12 AM |
| Pfizer beats by $0.03, misses on revenue
seekingalpha.com - October 31 at 10:43 AM |
| Gauging Analysts’ Views on Bristol-Myers Squibb Stock
finance.yahoo.com - October 31 at 10:42 AM |
